These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12221676)

  • 1. Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia.
    Smythe MA; Warkentin TE; Stephens JL; Zakalik D; Mattson JC
    Am J Hematol; 2002 Sep; 71(1):50-2. PubMed ID: 12221676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current agents for the treatment of patients with heparin-induced thrombocytopenia.
    Warkentin TE
    Curr Opin Pulm Med; 2002 Sep; 8(5):405-12. PubMed ID: 12172444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.
    Warkentin TE
    Thromb Haemost; 2008 Jan; 99(1):2-3. PubMed ID: 18217128
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia.
    Warkentin TE; Elavathil LJ; Hayward CP; Johnston MA; Russett JI; Kelton JG
    Ann Intern Med; 1997 Nov; 127(9):804-12. PubMed ID: 9382401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia.
    Srinivasan AF; Rice L; Bartholomew JR; Rangaswamy C; La Perna L; Thompson JE; Murphy S; Baker KR
    Arch Intern Med; 2004 Jan; 164(1):66-70. PubMed ID: 14718324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment: treatment of heparin-induced thrombocytopenia.
    Smythe MA; Warkentin TE
    Ann Pharmacother; 2002 Sep; 36(9):1483-4; author reply 1484. PubMed ID: 12196076
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
    Warkentin TE
    Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
    Bartholomew JR; Hursting MJ
    J Thromb Thrombolysis; 2005 Jun; 19(3):183-8. PubMed ID: 16082605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
    Bartholomew JR
    Chest; 2005 Feb; 127(2 Suppl):27S-34S. PubMed ID: 15706028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome.
    Warkentin TE; Cook RJ; Sarode R; Sloane DA; Crowther MA
    Blood; 2015 Jul; 126(4):486-93. PubMed ID: 25979950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for heparin-induced thrombocytopenia.
    Greinacher A
    Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management.
    Januzzi JL; Jang IK
    J Thromb Thrombolysis; 1999 Jun; 7(3):259-64. PubMed ID: 10375387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
    Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L
    Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous lepirudin for heparin-induced thrombocytopenia and when other anticoagulants fail: illustrative cases.
    Deitcher SR; Ngengwe R; Kaplan R; Liebman H; Kaplan K; Blinder M
    Clin Adv Hematol Oncol; 2004 Jun; 2(6):382-4; discussion 384-6. PubMed ID: 16163209
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.
    Hursting MJ; Lewis BE; Macfarlane DE
    Clin Appl Thromb Hemost; 2005 Jul; 11(3):279-87. PubMed ID: 16015413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin induced thrombocytopenia: diagnosis and management update.
    Ahmed I; Majeed A; Powell R
    Postgrad Med J; 2007 Sep; 83(983):575-82. PubMed ID: 17823223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.